Knopov; Victor

Patent Applications and Registrations

Patent applications and USPTO patent grants for Knopov; Victor.The latest application filed is for "cationic lipids for therapeutic agent delivery formulations".

Company Profile

8.25.28

Knopov; Victor - Oceanside CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Lipids for therapeutic agent delivery formulations Grant 11,103,583 - Payne , et al. August 31, 2	2021-08-31
Cationic lipids for therapeutic agent delivery formulations Grant 11,084,779 - Niitsu , et al. August 10, 2	2021-08-10
Cationic lipids for therapeutic agent delivery formulations Grant 10,961,181 - Niitsu , et al. March 30, 2	2021-03-30
Cationic Lipids For Therapeutic Agent Delivery Formulations App 20200199064 - Niitsu; Yoshiro ; et al.	2020-06-25
Compounds for targeting drug delivery and enhancing siRNA activity Grant 10,669,229 - Niitsu , et al.	2020-06-02
Lipids For Therapeutic Agent Delivery Formulations App 20200085957 - Payne; Joseph E. ; et al.	2020-03-19
Cationic lipids for therapeutic agent delivery formulations Grant 10,532,975 - Niitsu , et al. Ja	2020-01-14
Lipids for therapeutic agent delivery formulations Grant 10,441,659 - Payne , et al. Oc	2019-10-15
Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier Grant 10,195,145 - Niitsu , et al. Fe	2019-02-05
Retinoid-lipid drug carrier Grant 10,196,637 - Niitsu , et al. Fe	2019-02-05
Method of producing lipid nanoparticles for drug delivery Grant 10,155,945 - Knopov , et al. Dec	2018-12-18
COMPOUNDS FOR TARGETING DRUG DELIVERY AND ENHANCING siRNA ACTIVITY App 20180297938 - Niitsu; Yoshiro ; et al.	2018-10-18
Compounds for targeting drug delivery and enhancing siRNA activity Grant 10,100,004 - Niitsu , et al. October 16, 2	2018-10-16
Cationic Lipids For Therapeutic Agent Delivery Formulations App 20180208547 - Niitsu; Yoshiro ; et al.	2018-07-26
Compounds for targeting drug delivery and enhancing siRNA activity Grant 10,000,447 - Niitsu , et al. June 19, 2	2018-06-19
Cationic lipids for therapeutic agent delivery formulations Grant 9,963,424 - Niitsu , et al. May 8, 2	2018-05-08
Method For Treating Fibrosis Using Sirna And A Retinoid-lipid Drug Carrier App 20170175115 - Niitsu; Yoshiro ; et al.	2017-06-22
Method Of Producing Lipid Nanoparticles For Drug Delivery App 20170152516 - Knopov; Victor ; et al.	2017-06-01
Retinoid-lipid Drug Carrier App 20170081663 - Niitsu; Yoshiro ; et al.	2017-03-23
Method of producing lipid nanoparticles for drug delivery Grant 9,579,338 - Knopov , et al. February 28, 2	2017-02-28
COMPOUNDS FOR TARGETING DRUG DELIVERY AND ENHANCING siRNA ACTIVITY App 20170001950 - Niitsu; Yoshiro ; et al.	2017-01-05
COMPOUNDS FOR TARGETING DRUG DELIVERY AND ENHANCING siRNA ACTIVITY App 20170000893 - Niitsu; Yoshiro ; et al.	2017-01-05
Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier Grant 9,456,984 - Niitsu , et al. October 4, 2	2016-10-04
Compounds for targeting drug delivery and enhancing siRNA activity Grant 9,393,315 - Niitsu , et al. July 19, 2	2016-07-19
Cationic Lipids for Therapeutic Agent Delivery Formulations App 20160137593 - Niitsu; Yoshiro ; et al.	2016-05-19
Lipids for therapeutic agent delivery formulations Grant 9,308,267 - Payne , et al. April 12, 2	2016-04-12
Lipids for Therapeutic Agent Delivery Formulations App 20160074514 - Payne; Joseph E. ; et al.	2016-03-17
Cationic lipids for therapeutic agent delivery formulations Grant 9,242,001 - Niitsu , et al. January 26, 2	2016-01-26
Composition For Regenerating Normal Tissue From Fibrotic Tissue App 20160015656 - Niitsu; Yoshiro ; et al.	2016-01-21
Cationic lipids for therapeutic agent delivery formulations Grant 9,011,903 - Niitsu , et al. April 21, 2	2015-04-21
Single use system for sterilely producing lipid-nucleic acid particles Grant 8,956,572 - Knopov , et al. February 17, 2	2015-02-17
Retinoid-liposomes For Treating Fibrosis App 20140356413 - Niitsu; Yoshiro ; et al.	2014-12-04
Cationic Lipids For Therapeutic Agent Delivery Formulations App 20140294934 - Niitsu; Yoshiro ; et al.	2014-10-02
Retinoid-liposomes for treating fibrosis Grant 8,741,867 - Niitsu , et al. June 3, 2	2014-06-03
Retinoid-liposomes for enhancing modulation of HSP47 expression Grant 8,664,376 - Niitsu , et al. March 4, 2	2014-03-04
Lipids For Therapeutic Agent Delivery Formulations App 20130330401 - Payne; Joseph E. ; et al.	2013-12-12
Targeting Agent For Cancer Cell Or Cancer-associated Fibroblast App 20130210744 - Niitsu; Yoshiro ; et al.	2013-08-15
Composition For Regenerating Normal Tissue From Fibrotic Tissue App 20130171127 - Niitsu; Yoshiro ; et al.	2013-07-04
Drug Carrier And Drug Carrier Kit For Inhibiting Fibrosis App 20130171240 - Niitsu; Yoshiro ; et al.	2013-07-04
Single Use System For Sterilely Producing Lipid-nucleic Acid Particles App 20130164400 - Knopov; Victor ; et al.	2013-06-27
Method Of Producing Lipid Nanoparticles For Drug Delivery App 20130115274 - Knopov; Victor ; et al.	2013-05-09
Retinoid-liposomes For Treating Fibrosis App 20130071467 - Niitsu; Yoshiro ; et al.	2013-03-21
Retinoid-liposomes For Enhancing Modulation Of Hsp47 Expression App 20130071478 - Niitsu; Yoshiro ; et al.	2013-03-21
Cationic Lipids For Therapeutic Agent Delivery Formulations App 20130022665 - Niitsu; Yoshiro ; et al.	2013-01-24
COMPOUNDS FOR TARGETING DRUG DELIVERY AND ENHANCING siRNA ACTIVITY App 20130017249 - Niitsu; Yoshiro ; et al.	2013-01-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.